Accueil > Actualités > Découvrez les communications du consortium CALYM au 23ème congrès de l’EHA (...)

Découvrez les communications du consortium CALYM au 23ème congrès de l’EHA !

24/05/2018

Plusieurs communications orales ou posters des chercheurs de l’institut Carnot CALYM ont été sélectionnés dans le cadre du 23ème congrès de l’EHA qui se tiendra du 14 au 17 juin 2018 à Stockholm (Suède).

Communications orales

- Franck Morschhauser et al. RELEVANCE : PHASE III EFFICACY AND SAFETY STUDY OF LENALIDOMIDE PLUS RITUXIMAB (R2) VERSUS RITUXIMAB PLUS CHEMOTHERAPY, FOLLOWED BY RITUXIMAB, IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA


- Olivier Casasnovas et al.
FINAL ANALYSIS OF THE AHL2011 RANDOMIZED PHASE III LYSA STUDY COMPARING AN EARLY PET DRIVEN TREATMENT DE-ESCALATION TO A NOT PET-MONITORED STRATEGY IN PATIENTS WITH ADVANCED STAGES HODGKIN LYMPHOMA


- Sydney Dubois et al.
REFINING DIFFUSE LARGE B CELL LYMPHOMA SUBGROUPS USING INTEGRATED ANALYSIS OF MULTI-LEVEL MOLECULAR PROFILES IN A PROSPECTIVE COHORT : A LYSA STUDY

Poster avec pitch

- Christelle Vincent-Fabert et al.
MYD88 CONSTITUTIVE ACTIVATION IS DIRECTLY ABLE TO INDUCE INDOLENT LYMPHOPLASMACYTIC LYMPHOMA WITH MONOCLONAL IGM PEAK SECRETION IN 1 YEAR OLD MICE : A MODEL FOR WALDENSTROM MACROGLOBULINEMIA

- Antoine Papin et al.

THE DIALOG BETWEEN MANTLE CELL LYMPHOMA AND MONOCYTES/MACROPHAGES CAN BE DISRUPTED BY BTK INHIBITION AND MONITORED THROUGH CD163 MODULATION IN VIVO

Posters

- Jean-Baptiste Mear et al.
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER NIVOLUMAB TREATMENT IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA


- Christelle Vincent-Fabert et al.
SPLENIC MARGINAL ZONE B-CELL LYMPHOMAS DEPENDS ON PROGRAMMED DEATH-LIGAND 1 FOR CLONAL EMERGENCE AND ARE CONTROLLED BY T-CELLS FOR PROLIFERATION RATE